Method of deflecting emboli from the cerebral circulation

Information

  • Patent Grant
  • 8460335
  • Patent Number
    8,460,335
  • Date Filed
    Monday, September 11, 2006
    18 years ago
  • Date Issued
    Tuesday, June 11, 2013
    12 years ago
Abstract
Disclosed is a blood debris deflector, for preventing embolization during a surgical procedure, and methods for insertion and removal of the deflector. The method can include the steps of advancing an embolic deflection device through a first side branch vessel and into the main vessel, manipulating the deflection device such that it covers the opening to a second side branch vessel, and inverting the deflection device to remove the device from a patient.
Description
BACKGROUND OF THE INVENTION

Endovascular procedures are being used more and more frequently to treat various cardiac and vascular surgical problems. Blocked arteries can be treated with angioplasty, endarterectomy, and/or stenting, using minimally invasive endovascular approaches. Aneurysms can be repaired by endovascular techniques. Another use for endovascular surgery is the treatment of cardiac valvular disease. Valvuloplasties are already being done endovascularly and percutaneous valve replacement will surely follow, as it has already been tested in Europe. A major problem which is common to all these endovascular manipulations is that plaque found in the diseased vessels and valves can be dislodged and result in embolization. A major drawback to endovascular treatment of cardiac valves and arteries in the heart or thoracic aorta is that the dislodged debris can embolize into the carotid vessels resulting in catastrophic consequences such as stroke or even death. Attempts have been made to protect the cerebral vasculature with filters and other devices, but the inadequacy of the present art is obvious in the fact that these devices are rarely used. The plethora of pending patent applications for such protection devices suggests both the inadequacy of the present art and the need for improved devices.


The majority of devices described are filters. The problems with filters include difficulty in placement and retrieval as well as the possibility that a filter will fill abruptly causing blockage of the artery prior to removal of the filter. Cerebral protection requires placement of filters in the carotid arteries, which has the additional drawback of manipulation of the carotid vessels during filter placement while the cerebral vasculature is still unprotected. The risk of stroke for a carotid arteriogram done by cannulation of the carotid artery is 1% compared to an arteriogram done from injection into the aorta without selective cannulation which carries minimal risk. The risk of cannulating a carotid artery, navigating a catheter containing a filter into position, and deploying the filter would likely carry an even higher stroke risk. Patients requiring cardiac or aortic arch procedures are high risk candidates for having carotid disease. The chance of causing a stroke by the placement of the protective device into both carotid arteries makes the risk of using these devices prohibitive. The time and skill necessary to selectively cannulate both carotid arteries for filter placement has also contributed to the decision not to use them despite the stroke risk of unprotected cardiac and aortic arch procedures.


BRIEF DESCRIPTION OF THE INVENTION

The present invention comprises a deflector umbrella. In use, the invention is placed into the aortic arch by the Seldinger technique, preferably through the right arm but it may also be placed via the femoral artery. It is deployed in the aortic arch, where the umbrella is opened and pulled back into position to cover the ostia of both the brachiocephalic and left common carotid arteries.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 depicts brachial artery insertion of the deflector of the present invention.



FIG. 2 depicts femoral artery insertion of the deflector of the present invention.



FIGS. 3A-E depict the preferred method of deployment of the deflector of the present invention through the patient's right arm, thus allowing the deflector to be pulled back against the aortic wall to place it.



FIGS. 4A-F depict an alternative method of deployment of the deflector of the present invention through the femoral artery wherein the deflector is pushed against the aortic wall over the brachiocephalic and left common carotid openings.



FIG. 5 depicts the deflector of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The deflector (“umbrella”) of the present invention is positioned prior to any manipulation of the heart or thoracic aorta. It is simple to place and carries only the risk of catheterizing the aorta through the arm or leg, which is minimal. The umbrella is opened in the thoracic aorta and positioned to cover the ostia of both the brachiocephalic and left common carotid arteries. This position prevents clots or debris from entering the cerebral circulation through either the right or left carotid arteries with one simple device. Any debris from the cardiac or aortic procedure is deflected downstream. After the procedure is complete, the umbrella is inverted by means of a sheath extended over the catheter wire, which then wholly or partially covers the inverted umbrella prior to withdrawal. Should any clot or debris be attached to the outer side of the umbrella, it will be captured in the inverted umbrella and withdrawn. A major advantage of the device is that one size fits all, so it can be kept available in stock.


The umbrella is preferably dome-shaped with an adequate diameter to cover the ostia of both the brachiocephalic and left common carotid arteries, made of a material with pores or similar openings or permeability to allow the flow of blood into the cerebral circulation, but able to deflect or trap particles of a size which could cause a stroke (as depicted in FIG. 5.) The edge of the umbrella is preferably a flexible, porous donut shape, similar to the edge of a vaginal diaphragm, allowing a good seal with the curved aortic wall. The edge will preferably contain a nitinol wire ring. The dome part of the umbrella preferably has struts or ribs to assist in the opening and closing of the umbrella and to help maintain its position. The center of the umbrella preferably has a knob or similar projection on the inside surface to which the struts are attached. The deflector is pushed out of the delivery catheter with a tube which engages this knob. This knob helps with the opening of the umbrella. The knob remains attached to the umbrella “handle”, and the guide wire used to pull the umbrella into position. The device may also be made to open as a result of its construction material, for example, nitinol or polymer, elastically resuming its shape after being released from its sheath.


When the umbrella is to be closed, a tube or sheath of larger diameter than the knob is extended over the guide wire until it engages the knob. The umbrella is pulled back so that it inverts and is enclosed in the tube for removal. Inverting the device assures that no trapped particles escape into the bloodstream. The device is preferably constructed of polymer, fabric, metal, or a combination of these materials. The device may also optionally be equipped with radio-opaque markers or other structural parts which are radio-opaque for aid in placement guidance.


Another embodiment of the device has a rolled edge.


The device may also have a flat porous edge.


Another embodiment of the device has no struts, but instead has a nitinol skeleton.


Another embodiment has multiple wires to position and anchor the device.


Another embodiment of the device has anchors at the edges which help to maintain its position during the procedure.


Another embodiment of the device is parachute-like, with a ring gasket at its edge. The gasket would be held firmly in position over the ostia of the brachiocephalic and left common carotid arteries. The billowy porous middle section would deflect or trap clot and debris on its exterior surface while causing minimal resistance in the aorta. The middle portion would be inverted as it is removed by pulling on wires attached to its center, capturing any clot stuck to it.


Alternatively, the center of the device may comprise a screen, which fits more snugly against the aortic wall, with a very small profile, further preventing resistance to downstream aortic bloodflow. Again the device would be removed by inversion, capturing any debris stuck to it prior to removal.


The device may be round, oval or rectangular or of another shape to assist in sealing of the edge against the wall of the aorta, covering the ostia of both the brachiocephalic and left common carotid arteries and maintaining a low profile within the lumen of the aorta.


This device could be modified in size in another embodiment in order to be used to cover the ostia of different vessels.


The device may be coated with something which prevents clots (e.g., heparin).


The device may be deployed through an artery of the arm, or through the femoral artery. The preferred method would be through the right arm, if possible, as this would allow the device to be pulled back against the aortic wall to place it (FIG. 3).


When deployed through the femoral artery (FIG. 4), the opening of the umbrella would be different and the umbrella would be pushed against the aortic wall over the brachiocephalic and left common carotid openings rather than being pulled back. A wire would be cannulated into the brachiocephalic artery in this case to ensure correct positioning of the device. The device would be modified to allow this method of delivery and positioning. In this embodiment, the knob would be on the outside of the umbrella and the handle would be a firm catheter to allow pushing. In this case, retrieval of the device would involve inversion and closing of the “umbrella” by drawstring or another method.


Brachial Artery Insertion of the Device.


Referring now to FIG. 1, the deflector 100 is delivered via percutaneous insertion into the right brachial artery 20 and is guided into the aortic arch 12. There it is deployed and then pulled back into position to cover the ostia of the innominate 16 and left common carotid 24 arteries. The device 100 deflects embolic debris during aortic and cardiac procedures, allowing the flow of blood through into the cerebral circulation (carotid arteries) but not permitting the passage of particulate debris.


Femoral Artery Insertion of the Device.


Referring now to FIG. 2, the deflector 100 is delivered via percutaneous insertion into the femoral artery 30 and is guided into the aortic arch 12. After catheterization of the innominate artery 16, the device 100 is passed over the wire and brought into position covering the ostia of the innominate 16 and left common carotid 24 arteries.


Deployment of the Device via Arm Approach.


Referring now to FIGS. 3A-E, percutaneous access to the circulation via the right arm is performed and a wire guided into the aortic arch 12 after exiting the innominate artery 16. The device 100 is placed over the wire and guided into the aortic arch 12. The covering outer sheath 102 which encapsulates the device 100 is retracted (FIG. 3A), exposing the device 100 to the aortic bloodstream. The device 100 is then opened in the aortic arch 12 (FIG. 3B). The device 100 is pulled back into position, covering the ostia of the innominate 16 and left common carotid 24 artery. The device 100 allows the passage of blood through to the carotid arteries 22, 24, but deflects debris generated by aortic or cardiac surgery away from these arteries. At the completion of the debris producing concomitant procedure, the device 100 is closed by inverting the covering cap 101 (FIG. 3D). The device 100 is then withdrawn into a covering sheath 102 (FIG. 3E) to completely encapsulate it prior to removal from the arm access artery. Any trapped debris is enfolded within the closed cap 101, safely and securely within the covering sheath 102.


Deployment of the Device via Femoral Approach.


Referring now to FIGS. 4A-F, the innominate artery 16 is catheterized with a wire 104 placed via femoral access. Over the wire 104, the device 100 is guided into position in the aortic arch 12, where it is deployed by unsheathing (FIG. 4A). The device 100 is then pushed over the wire 104 into position securely covering the ostia of the innominate 16 and left common carotid 24 arteries (FIG. 4B). The device 100 allows the passage of blood through to the carotid arteries 22, 24, but deflects debris generated by aortic or cardiac surgery away from these arteries 22, 24. At the completion of the debris producing concomitant procedure, the device 100 is closed by inverting the covering cap 101 (FIG. 4C), shown here by means of drawstrings. The device 100 is then collapsed (FIG. 4D) and withdrawn into a covering sheath 102 (FIG. 4E) to completely encapsulate it prior to removal from the femoral artery 30. Any trapped debris is enfolded within the closed cap 101, safely and securely within the covering sheath 102. The wire 104 and device 100 are then withdrawn from the femoral access.


Embolic Deflecting Device.


Referring now to FIG. 5, the deflector 100 of the present invention, viewed from above, is dome-shaped with an adequate diameter to cover the ostia of both the brachiocephalic 16 and left common carotid 24 arteries, made of a material with pores to allow the flow of blood, but deflect or trap particles of a size which could cause a stroke. The edge 110 of the umbrella 100 is a flexible, porous donut, similar to the edge of a diaphragm, allowing a good seal with the curved aortic wall. The edge 110 will preferably contain a nitinol wire ring. The dome part of the umbrella 100 has struts 120 to assist in the opening and closing of the umbrella 100 and to help maintain its position.


The center of the umbrella has a knob 130 on the inside surface to which the struts 120 are attached. The device 100 is pushed out of the delivery catheter with a tube which engages this knob 130. This knob 130 helps with the opening of the umbrella. The knob 130 remains attached to the umbrella “handle”, the guide wire used to pull the umbrella into position. The device 100 may also open as a result of the material it is made of, nitinol or polymer, resuming its shape after being released from its sheath.


The device is constructed of polymer, fabric, metal, or a combination of these materials. The device may be provided with radioopaque markers or metal parts which are radioopaque.


Another embodiment of the device has a rolled edge. The device could also have a flat porous edge. Another embodiment of the device has no struts, but a nitinol skeleton. Another embodiment has multiple wires to position and anchor the device. Another embodiment of the device has anchors at the edges which help to maintain its position during the procedure.


Another embodiment of the device is parachute-like, with a ring gasket at its edge. The gasket would be held firmly in position over the ostia of the brachiocephalic and left common carotid arteries. The billowy porous middle section would deflect or trap clot and debris on its exterior surface while causing minimal resistance in the aorta. The middle portion would be inverted as it is removed by pulling on wires attached to its center, capturing any clot stuck to it. Alternatively, the center of the device could be a screen, which fits more snugly against the aortic wall, with a very small profile, further preventing resistance. Again the device would be removed by inversion, capturing any clot stuck to it prior to removal.


The device may be round, oval or rectangular or of another shape to assist in sealing of the edge against the wall of the aorta, covering the ostia of both the brachiocephalic and left common carotid arteries and maintaining a low profile within the lumen of the aorta. This device could be modified in size in another embodiment in order to be used to cover the ostia of different vessels. The device may be coated with something which prevents clots (e.g. heparin).


While the invention has been described in its preferred embodiments, it is to be understood that the words which have been used are words of description rather than of limitation and that changes may be made within the purview of the appended claims without departing from the true scope and spirit of the invention in its broader aspects. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the spirit of the invention. The inventor further requires that the scope accorded the claims be in accordance with the broadest possible construction available under the law as it exists on the date of filing hereof (and of the application from which this application obtains priority, if any) and that no narrowing of the scope of the appended claims be allowed due to subsequent changes in the law, as such a narrowing would constitute an ex post facto adjudication, and a taking without due process or just compensation.

Claims
  • 1. A method of deflecting emboli flowing within a main vessel from entering first and second side branch vessels, comprising the steps of: advancing an expandable emboli deflection device through the first side branch vessel and into the main vessel, the emboli deflection device attached to a distal end of an elongate shaft; andmanipulating the deflection device such that it expands to cover the ostia of each of the first and second side branch vessels, wherein manipulating the deflection device comprises applying traction to the elongate shaft to create a seal between the deflection device and the main vessel wall over the ostia of the first and second side branch vessels;wherein the deflection device permits blood flow from the main vessel into each of the first and second side branch vessels, but deflects emboli from entering the first and second side branch vessels.
  • 2. The method of claim 1 wherein the first branch vessel is the brachiocephalic artery and the main vessel is the aorta.
  • 3. The method of claim 1, wherein the second side branch vessel is the left common carotid artery.
  • 4. The method of claim 1, wherein the emboli deflection device is advanced through a sheath that removably houses the emboli deflection device.
  • 5. The method of claim 1, wherein the method is performed in conjunction with a cardiac procedure.
  • 6. The method of claim 5, wherein the method is performed in conjunction with a cardiac valve replacement procedure.
  • 7. The method of claim 5, wherein the method is performed in conjunction with a valvuloplasty procedure.
  • 8. The method of claim 1, wherein the method is performed in conjunction with an aortic repair procedure.
  • 9. The method of claim 6, wherein traction to the elongate shaft to create a seal is maintained during the valve replacement procedure.
  • 10. The method of claim 1, wherein the manipulating step comprises advancing at least a portion of the deflection device from an axial orientation to a lateral orientation.
  • 11. The method of claim 1, wherein the deflection device has a configuration having a concave surface facing the ostia of each of the first and second side branch vessels after the manipulating step.
US Referenced Citations (119)
Number Name Date Kind
4619246 Molgaard-Nielsen et al. Oct 1986 A
5634942 Chevillon et al. Jun 1997 A
5662671 Barbut et al. Sep 1997 A
5695519 Summers et al. Dec 1997 A
5769816 Barbut et al. Jun 1998 A
5911734 Tsugita et al. Jun 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
6027520 Tsugita et al. Feb 2000 A
6042598 Tsugita et al. Mar 2000 A
6117154 Barbut et al. Sep 2000 A
6152946 Broome et al. Nov 2000 A
6235045 Barbut et al. May 2001 B1
6245088 Lowery Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254563 Macoviak et al. Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6336934 Gilson et al. Jan 2002 B1
6346116 Brooks et al. Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6371935 Macoviak et al. Apr 2002 B1
6371969 Tsugita et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6391044 Yadav et al. May 2002 B1
6395014 Macoviak et al. May 2002 B1
6423086 Barbut et al. Jul 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6499487 McKenzie et al. Dec 2002 B1
6511497 Braun et al. Jan 2003 B1
6537297 Tsugita et al. Mar 2003 B2
6547760 Samson et al. Apr 2003 B1
6626937 Cox Sep 2003 B1
6645221 Richter Nov 2003 B1
6673089 Yassour et al. Jan 2004 B1
6695811 Samson et al. Feb 2004 B2
6695864 Macoviak et al. Feb 2004 B2
6706053 Boylan et al. Mar 2004 B1
6726702 Khosravi Apr 2004 B2
6740112 Yodfat et al. May 2004 B2
6866680 Yassour et al. Mar 2005 B2
6962598 Linder et al. Nov 2005 B2
6989019 Mazzocchi et al. Jan 2006 B2
6994092 van der Burg et al. Feb 2006 B2
7083633 Morrill et al. Aug 2006 B2
7112213 Maahs Sep 2006 B2
7144408 Keegan et al. Dec 2006 B2
7172614 Boyle Feb 2007 B2
7174636 Lowe Feb 2007 B2
7217255 Boyle et al. May 2007 B2
7229463 Sutton et al. Jun 2007 B2
7229464 Hanson et al. Jun 2007 B2
7232453 Shimon Jun 2007 B2
7235061 Tsugita Jun 2007 B2
7241304 Boyle et al. Jul 2007 B2
7241305 Ladd Jul 2007 B2
7244267 Huter et al. Jul 2007 B2
7252675 Denison et al. Aug 2007 B2
7261727 Thielen et al. Aug 2007 B2
7303575 Ogle Dec 2007 B2
7323001 Clubb et al. Jan 2008 B2
7367985 Mazzocchi et al. May 2008 B2
7604650 Bergheim Oct 2009 B2
7618446 Andersen et al. Nov 2009 B2
7670356 Mazzocchi Mar 2010 B2
20020077596 McKenzie et al. Jun 2002 A1
20020128679 Turovskiy et al. Sep 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020138094 Borillo et al. Sep 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020169437 Macoviak et al. Nov 2002 A1
20020169474 Kusleika Nov 2002 A1
20030120304 Kaganov et al. Jun 2003 A1
20030125801 Yodfat et al. Jul 2003 A1
20030158574 Esch et al. Aug 2003 A1
20030208224 Broome Nov 2003 A1
20030220667 van der Burg et al. Nov 2003 A1
20040010307 Grad et al. Jan 2004 A1
20040010308 Zafrir-Pachter Jan 2004 A1
20040024416 Yodfat et al. Feb 2004 A1
20040034386 Fulton et al. Feb 2004 A1
20040088002 Boyle et al. May 2004 A1
20040093014 Ho et al. May 2004 A1
20040111111 Lin Jun 2004 A1
20040158281 Boylan et al. Aug 2004 A1
20040167568 Boyle et al. Aug 2004 A1
20040167613 Yodfat et al. Aug 2004 A1
20040215167 Belson Oct 2004 A1
20050085847 Galdonik et al. Apr 2005 A1
20050119688 Bergheim Jun 2005 A1
20050267516 Soleimani et al. Dec 2005 A1
20050283185 Linder et al. Dec 2005 A1
20060015138 Gertner Jan 2006 A1
20060015141 Linder et al. Jan 2006 A1
20060058833 VanCamp et al. Mar 2006 A1
20060129180 Tsugita et al. Jun 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060241678 Johnson et al. Oct 2006 A1
20060253148 Leone et al. Nov 2006 A1
20060287670 Pal Dec 2006 A1
20060293706 Shimon Dec 2006 A1
20070043435 Seguin et al. Feb 2007 A1
20070123931 Gilson et al. May 2007 A1
20070135834 Clubb et al. Jun 2007 A1
20070270901 Shimon et al. Nov 2007 A1
20080004688 Spenser et al. Jan 2008 A1
20080051807 St. Goar et al. Feb 2008 A1
20080065146 Mazzocchi et al. Mar 2008 A1
20080065147 Mazzocchi et al. Mar 2008 A1
20080109055 Hlavka et al. May 2008 A1
20080114440 Hlavka et al. May 2008 A1
20080140110 Spence Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080255603 Naor et al. Oct 2008 A1
20080275489 Kinst et al. Nov 2008 A1
20090062908 Bonhoeffer et al. Mar 2009 A1
20100312268 Belson Dec 2010 A1
Foreign Referenced Citations (1)
Number Date Country
WO 2006076505 Jul 2006 WO
Non-Patent Literature Citations (8)
Entry
U.S. Appl. No. 12/440,839, filed Mar. 11, 2009, Carpenter.
U.S. Appl. No. 12/685,539, filed Jan. 11, 2010, Carpenter et al.
U.S. Appl. No. 12/685,560, filed Jan. 11, 2010, Carpenter et al.
U.S. Appl. No. 12/685,570, filed Jan. 11, 2010, Carpenter et al.
U.S. Appl. No. 12/685,591, filed Jan. 11, 2010, Carpenter et al.
International Preliminary Report on Patentability, PCT/US07/78170 mailed Mar. 17, 2009, p. 5.
International Search Report dated Mar. 2, 2010 for PCT App. No. PCT/US2010/020530.
U.S. Appl. No. 12/892,767, filed Sep. 28, 2010, Belson.
Related Publications (1)
Number Date Country
20080065145 A1 Mar 2008 US